Auburn Hills, MI, United States of America

Shihong Luo

This inventor holds 1 USPTO granted patent. Top assignee: Biosteed Gene Expression Tech. Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shihong Luo. Retrieved from https://idiyas.com/inventor/shihong-luo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shihong Luo: Innovator in Biomedicine

Introduction

Shihong Luo is a notable inventor based in Auburn Hills, MI (US). He has made significant contributions to the field of biomedicine, particularly in the development of modified interferon therapies. His work focuses on enhancing the efficacy of treatments for viral infections.

Latest Patents

Luo holds a patent for "Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof." This invention relates to interferon-α2b modified with Y-shaped branched polyethylene glycol (PEG) at a single Lys residue. The peglated IFN-α2b can be utilized in the preparation of a medicament for treating diseases, such as viral infections like Hepatitis C. He has 1 patent to his name.

Career Highlights

Shihong Luo is associated with Biosteed Gene Expression Tech. Co., Ltd., where he applies his expertise in biomedicine. His innovative approach to drug development has positioned him as a key figure in the industry.

Collaborations

Luo has collaborated with notable colleagues, including Weidong Zhou and Qingjiang Xiao. Their combined efforts contribute to advancements in medical research and therapeutic solutions.

Conclusion

Shihong Luo's work in modifying interferon therapies showcases his commitment to improving treatment options for viral infections. His innovative contributions continue to impact the field of biomedicine positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…